AI assistant
Sending…
TransMedics Group, Inc. — Director's Dealing 2019
Aug 8, 2019
31201_dirs_2019-08-07_6462f079-dcde-45f6-a8c7-c182bee73d7b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TransMedics Group, Inc. (TMDX)
CIK: 0001756262
Period of Report: 2019-08-05
Reporting Person: DAMME LAURA (VP, Clinical Affairs)
More from TransMedics Group, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 21
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 24
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 20